Erika Salyine Gal - GMP Lead Auditor - TEVA Pharmaceutical Works Ltd., Pharma QA Division | LinkedIn
![Generic Industry's Perspective on the New GMP Initiative 2002 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory Compliance TEVA. - ppt download Generic Industry's Perspective on the New GMP Initiative 2002 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory Compliance TEVA. - ppt download](https://slideplayer.com/10544810/36/images/slide_1.jpg)
Generic Industry's Perspective on the New GMP Initiative 2002 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory Compliance TEVA. - ppt download
![Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States | Business Wire Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States | Business Wire](https://mms.businesswire.com/media/20210622006088/en/739014/22/teva_RGB_JPEG.jpg)